NSC-631570 (Ukrain) in the palliative treatment of pancreatic cancer
β Scribed by Frank Gansauge; Marco Ramadani; Jochen Pressmar; Susanne Gansauge; Bernd Muehling; Kerstin Stecker; Gregor Cammerer; Gerd Leder; Hans G. Beger
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 79 KB
- Volume
- 386
- Category
- Article
- ISSN
- 1435-2451
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The records of 72 consecutive patients with unresectable pancreatic cancer treated between 1974 and 1986 were evaluated to determine whether gastroenterostomy should be performed on a routine basis at initial intervention or on a therapeutic basis. Fourteen patients underwent an explorative laparoto
The effect of the radiosensitizer razoxane was prospectively evaluated in advanced and recurrent gastric cancer. Endpoints of the study were mainly palliation, local response rates, and achievement of local control. From 1984 to 1993, razoxane (Rz) was given together with radiation therapy (R") to 2
Seventy patients with primary pulmonary cancer with metastasis received a micronized form of hexamethylmelamine (HXM) (NSC-13875) at dosages of 8 to 12 mg/kg/day given orally. Most patients had some nausea or vomiting